USBIomax品牌有哪些产品，中国代理商
欢迎广大客户咨询订货，在线QQ：3507623898（点击即可添加QQ好友咨询）
4000-520-616
来自Usbiomax的组织阵列或组织微阵列包括正常，恶性或转移形式。组织阵列和组织微阵列可用于验证潜在生物学靶标在诊断，治疗学和研究新蛋白质标记物和基因的开发中的临床相关性。组织阵列（组织微阵列或组织芯片）含有蛋白质，RNA或DNA分子，因此提供高通量平台，用于快速分析与患者的疾病诊断，预后和治疗相关的分子标记。USBiomax还提供定制组织阵列以及免疫组织化学（IHC）染色和组织阵列或组织微阵列上的原位杂交（ISH）服务。
| Thumb | Name | Description | Cores | Cases |
| HLivH090BC01 | Livercancertissuearraywithmatchedcanceradjacentnormaltissue,includingpathologygrade,TNMandclinicalstage,70cases/90cores | 90 | 70 | |
| AC451 | Multipleorgancondylomaacuminatumtissuearray,45cases/45cores | 45 | 45 | |
| AD2081 | Adrenalglanddiseasespectrum(adrenalcancerprogression)tissuearray,100cases/200cores | 200 | 100 | |
 | AG801 | Adrenaltumortissuearray,80cases/80cores | 80 | 80 |
| AMS541 | Mouse(FBVstrain)normaltissuearray,cover22organs/anatomicsites,3cases/54cores | 54 | 3 | |
| AMS544 | Mousenormaltissuearray,covering22organ/anatomicsites,3cases/54cores | 54 | 3 | |
 | AR301 | Multiplepartsofarterytissueandatherosclerosistissuearray,22cases/30cores | 30 | 22 |
 | ART661 | Rat(Wistarstrain)normaltissuearray,coveringallmajororgans,non-overlappingwithART662,22cases/66cores | 66 | 22 |
| ASM221 | Cynomonkeynormaltissuearray,22cases/22cores | 22 | 22 | |
 | BB01011 | Gastriculcertissuearray,14cases/24cores,replacedbyBB01011a | 24 | 14 |
 | BB01011a | Gastriculcerativetissuearraywithnormalgastrictissue,14cases/24cores,replacingBB01011 | 24 | 14 |
 | BB08015 | Breastductalintraepithelialneoplasiaandcancertissuearray,includingTNM,clinicalstageandpathologygrade,24cases/48cores | 48 | 24 |
 | BB10011 | Cervicalintraepithelialneoplasiaandcancertissuearray,includingpathologygrade,TNMandclinicalstage,24cases/48cores | 48 | 24 |
 | BB19012 | Prostateintraepithelialneoplasiaandcancertissuearray,includingTNM,clinicalstageandpathologygrade,24cases/48cores | 48 | 24 |
 | BBS02011 | Esophagealmucouschronicinflammation,esophagealintraepithelialneoplasia,esophagealcancertissuearray,includingTNM,clinicalstageandpathologygrade,60cases/120cores, | 120 | 60 |
 | BBS14011 | Pancreatitistissuearray,48cases/48cores | 48 | 48 |
 | BC000110 | Colorectalcancertissuearray,85cases/170cores | 170 | 85 |
| BC000111 | Multipleorgancancertissuearray,39cases/39cores，replacedbyBC000111a | 39 | 39 | |
 | BC000111a | Multipleorgancancertissuearray,includingTNM,clinicalstageandpathologygrade,39cases/39cores,replacedbyBC000111b | 39 | 39 |
 | BC000111b | Multipleorgancancertissuearray,includingTNM,clinicalstageandpathologygrade,39cases/39cores,replacingBC000111a | 39 | 39 |
 | BC000119 | Multi-organcarcinomatissuearray,includingTNM,clinicalstageandpathologygrade,200cases/200cores,replacedbyBC000119a | 200 | 200 |
 | BC000119a | Multi-organcarcinomatissuearray,includingpathologygrade,TNMandclinicalstage,190cases/190cores,replacingBC000119 | 190 | 190 |
 | BC000120a | Multipleorgancarcinomatissuearray,includingTNM,clinicalstageandpathologygrade,190cases/190cores,replacingBC000120 | 190 | 190 |
 | BC00014 | Multipleorgandiseasedtissuearray,63cases/63cores,replacedbyMC631 | 63 | 63 |
 | BC00019 | Multipleorgansquamouscellcarcinomatissuearray,63cases/63cores | 63 | 63 |
| BC00111 | Multipleorgannormalanddiseasedtissuearray(replacedbyMCN601),54cases/60cores | 60 | 54 | |
 | BC001113a | Esophagus,cardiacancertissuearraywithnormaltissue,includingTNMandpathologygrade,50cases/50cores,replacingBC001113 | 50 | 50 |
 | BC00112 | Multipleorganpairedcancerandnormal(8types)tissuearray,48cases/48cores | 48 | 48 |
 | BC001128 | Topfivecancertissuearray,includingTNMandpathologygrade,150cases/175cores,replacedbyMC1801 | 175 | 150 |
 | BC00113 | Multipleorganstumorandnormaltissue,48cases/48cores | 48 | 48 |
| BC001130 | Pancreaticcarcinomaandmulti-organadjacenttissuearray,includingTNM,clinicalstageandpathologygrade,81cases/121cores | 121 | 81 | |
 | BC001134 | Multipleorganstumorandnormaltissuearray,includingTNM,clinicalstageandpathologygrade,150cases/150cores,replacedbyBC001134a | 150 | 150 |
| BC001134a | Multipleorganstumorandnormaltissuearray,includingTNM,clinicalstageandpathologygrade,150cases/150cores,replacingBC001134 | 150 | 150 | |
| BC00114 | Multipleorgannormalanddiseasedtissuearray,36cases/60cores | 60 | 36 | |
 | BC001157 | Multipleorgantumortissuearraywithnormaltissueascontrol,includingTNM,clinicalstageandpathologygrade,72cases/72cores | 72 | 72 |
 | BC00116 | Carcinomawithadjacent-tissuecombinedpaneltissuearray,44cases/48cores | 48 | 44 |
 | BC00119 | Multipleorgantumortissuearray,includingpathologygrade,TNMandclinicalstage,32cases/32cores,replacedbyMC483 | 32 | 32 |
 | BC00432 | Multipleorgantumorandadjacentnormaltissuearray,39cases/43cores | 43 | 39 |
| BC01001 | Tissuearrayofgastricdiseasesbiopsiedfromgastroscope,includingTNM,clinicalstageandpathologygrade,18cases/18cores | 18 | 18 | |
 | BC01011 | Stomachcarcinoma(multi-tissuecombinedpanel)tissuearray,24cases/72cores,replacedbyST721 | 72 | 24 |
 | BC01014 | Stomachcarcinomatissuearray(multi-tissuecombinedpanel),71cases/72cores,replacedbyST807 | 72 | 71 |
 | BC01022 | Stomachadenocarcinoma(combinationofadjacentandnormal)tissuearray,21cases/63cores | 63 | 21 |
 | BC01023 | Stomachadenocarcinoma(combinationofadjacentandnormal)tissuearray,21cases/63cores | 63 | 21 |
 | BC01024 | Stomachadenocarcinoma(combinationofadjacentandnormal)tissuearray,21cases/63cores,replacedbyST722 | 63 | 21 |
 | BC01071 | Carcinomaofstomach,liverandrectumtissuearray,45cases/48cores,replacedbyBC01071a | 48 | 45 |
 | BC01071a | Multipleorgancancertissuearray,includingTNM,clinicalstageandpathologygrade,48cases/48cores,replacingBC01071 | 48 | 48 |
 | BC02011 | Multipleesophagealcancertissuearray,69cases/72cores | 72 | 69 |
 | BC02012 | Esophagealcarcinoma(multi-tissuecombinedpanel)tissuearray,72cases/72cores | 72 | 72 |
 | BC02013 | Esophagealcarcinoma(multi-tissuecombinedpanel)tissuearray,72cases/72cores | 72 | 72 |
 | BC02021 | Esophagussquamouscarcinoma(combinationofadjacentandnormal)tissuearray,18cases/54cores | 54 | 18 |
 | BC02022 | Esophagussquamouscellcarcinoma(combinationofadjacentandnormal)tissuearray,18cases/54cores | 54 | 18 |
 | BC02023 | Esophagussquamouscellcarcinoma(combinationofadjacentandnormal)tissuearray,18cases/54cores,replacedbyES722 | 54 | 18 |
 | BC02111 | Esophagealadenocarcinomatissuearraywithmatchednormaladjacenttissue,23cases/80cores | 80 | 23 |
 | BC03002 | Liverdiseasespectrumtissuearray,includingTNM,clinicalstageandpathologygrade,40cases/80cores | 80 | 40 |
 | BC03013 | Livercarcinoma(multi-tissuecombinedpanel)tissuearray,63cases/63cores,replacedbyLV723 | 63 | 63 |
 | BC03021 | Livercarcinoma(combinationofadjacentandnormal)tissuearray,42cases/63cores,replacedbyLV803 | 63 | 42 |
 | BC03116a | Livercancerandnormaltissuearray,includingTNM,clinicalstageandpathologygrade,70cases/70cores,replacedbyBC03116b | 70 | 70 |
| BC03116b | Livercancerandnormaltissuearray,includingpathologygrade,TNMandclinicalstage,70cases/70cores,replacingBC03116a | 70 | 70 | |
 | BC03117 | Livercancer,livercirrhosistissuearraywithnormaltissueascontrol,includingTNM,clinicalstage,pathologygradeandhistoryofhepatitis,70cases/80cores | 80 | 70 |
 | BC03118 | Livercarcinomaandnormaltissuearray,includingTNM,clinicalstageandpathologygrade,100cases/200cores | 200 | 100 |
 | BC03119a | Livercarcinomaandnormaltissuearray,includingTNM,clinicalstageandpathologygrade120cases/120cores,replacedbyBC03119b | 120 | 120 |
 | BC03119b | Livercarcinomaandnormaltissuearray,includingTNM,clinicalstageandpathologygrade,120cases/120cores,replacedbyBC03119c | 120 | 120 |
 | BC03119c | Livercancerwithlivertissuearray,includingpathologygrade,TNMandclinicalstage,120cases/120cores,replacingBC03119b | 120 | 120 |
 | BC04002 | Lungdiseasespectrumtissuearray,includingTNM,clinicalstageandpathologygrade,99cases/100cores,replacedbyBC04002a | 100 | 99 |
 | BC04002a | Lungdiseasespectrumtissuearray,includingTNM,clinicalstageandpathologygrade,100cases/100cores,replacingBC04002 | 100 | 100 |
| BC04011 | Lungcancertissuearray,includingpathologygrade,23cases/63cores,replacedbyLC721 | 63 | 23 | |
 | BC04013 | Non-smallcelllungcarcinomatissuearray,63cases/63core,replacedbyLC806 | 63 | 63 |
 | BC04014 | Non-smallcelllungcarcinoma(NSCLC)andsmallcelllungcancer(SCLC)tissuearray,63cases/63cores,replacedbyLC813,LC807 | 72 | 72 |
 | BC04015 | Lungcarcinoma(multi-tissuecombinedpanel)tissuearray,23cases/63cores | 63 | 23 |
 | BC04016 | Lungcarcinomatissuearray,72cases/72cores,replacedbyLC726 | 72 | 72 |
| BC04021 | Lungcarcinoma(multi-tissuecombinedpanel)tissuearray,18cases/54cores,replacedbyBC04021a | 54 | 18 |
蚂蚁淘(ebiomall）是一家生命科学领域的垂直电商平台，公司专注生物医学科研用品的 全球导购和品牌推广，为海外厂方与国内代理经销商搭建跨境贸易系统和交流平台。
产品齐全，200+分类，1000+品牌，500万+产品信息。100%正品，专业售后，到货快，在线
下单，简单轻松，节省科学家宝贵的科研时间。
借助互联网平等而开放的力量，矢志实现生命科学领域全球的信息同步，我们相信一群充满梦想的人，可以凭借着专业与执着，让你的购物更轻松！
Thermofisher旗下Gibco培养系列、ABI细胞计数仪及PCR仪、Invitrogen分子生物学试剂及qubit3.0、Ambion的RNA相关试剂、Molecular probes试剂、Pierce蛋白相关试剂盒、NanodropOne/OneC；Parafilm封口膜；Viskase透析袋；Sigma-Aldrich试剂；AccuStandard标准品；Millipore抗体；Glenresearch核酸合成试剂；Bio-Rad电泳仪及PCR仪；Nanocs的PEG聚合物； chromotek羊驼抗体； polysciences转染试剂； Echelon-inc 脂类研究试剂盒； R&D Systems抗体及ELISA试剂盒； Jackson二抗及封闭血清； Biotium荧光染料；NEB内切酶及NGS相关产品； Athens Research & Technology人类蛋白及抗血清； Illumina二代测试试剂盒； Tocris 小分子试剂； TwistDx恒温扩增试剂盒（RPA）； Enzymatics二代测序酶；Novus抗体及Elisa试剂盒；AGScientific潮霉素B、G-418；Plantmedia植物培养系列及抗体；Agilent2100生物分析仪；BIOLOG耗材；Biomatik的Elisa试剂盒；COVARIS基因打断仪；CST抗体；Dharmacon的siRNA产品。
